Keratinocyte growth factor in acute lung injury to reduce pulmonary dysfunction – a randomised placebo-controlled trial (KARE): study protocol

BACKGROUND: Acute lung injury is a common, devastating clinical syndrome associated with substantial mortality and morbidity with currently no proven therapeutic interventional strategy to improve patient outcomes. The objectives of this study are to test the potential therapeutic effects of keratin...

Descripción completa

Detalles Bibliográficos
Autores principales: Cross, Laurence JM, O’Kane, Cecilia M, McDowell, Cliona, Elborn, Jospeh J, Matthay, Michael A, McAuley, Daniel F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3620926/
https://www.ncbi.nlm.nih.gov/pubmed/23419093
http://dx.doi.org/10.1186/1745-6215-14-51

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3620926/
https://www.ncbi.nlm.nih.gov/pubmed/23419093
http://dx.doi.org/10.1186/1745-6215-14-51

Ejemplares similares